Skip to content

Use of Quercetin Bar as performance enhancer at high altitude (HA)

Quercetin food bar as performance enhancer at high altitude (HA)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042629
Enrollment
150
Registered
2022-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intervention: Quercetin Bar : It is a Placebo controlled two armed study. In one study Quercetin bar (500 mg) will be supplied to subjects (100 subjects) every day morning for 2 weeks

Sponsors

DEFENCE RESEARCH AND DEVELOPMENTAL ORGANIZATION
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age from 20 years to 50 years Gender : males and/or females Details: It is a placebo controlled two arm study Subject in healthy males and/or females adult, aged 20-50 years on the day of enrolment, subject weight at least 45 kg, subject willing to participate

Exclusion criteria

Exclusion criteria: Subject has any clinically significant illness which is likely to impact to safety for patient or may affect to results of the study Subject has a known hypersensitivity or allergy to quercetin Study subject is participant in other drug trial Study subject unwilling to sign informed consent Study subject is unlikely to complete the study

Design outcomes

Primary

MeasureTime frame
no adverse effect, performance improvementTimepoint: 1. 0 day, 7 th day and 15th day of the study at 9000 to 12000 ft HA 2. 0 day , 15th day and 30th day of the study at above 12000 ft HA

Secondary

MeasureTime frame
effect of quercetin on Plasma Oxidative stress status and inflammatory markersTimepoint: 2 weeks and 4 weeks

Countries

India

Contacts

Public ContactMrs Vandana Kirar

DIPAS

saradasks@gmail.com9811576850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026